New guidelines for cardiovascular management in noncardiac surgery released

The ven­ture arm of Nvidia, the su­per­com­put­ing gi­ant ris­ing up the world’s most valu­able com­pa­nies chart, is back­ing a com­pu­ta­tion­al drug dis­cov­ery start­up that’s head­ed

The platform targets tumour-specific protease to concentrate potent treatments within the tumour microenvironment. Credit: MUNGKHOOD STUDIO/Shutterstock. Avacta Therapeutics has entered a strategic collaboration with Tempus